VIKING GLOBAL INVESTORS LP filings

This page lists the SEC filings reported by VIKING GLOBAL INVESTORS LP.

SEC filings by VIKING GLOBAL INVESTORS LP (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2020-12-28VIKING GLOBAL INVESTORS LPAbCellera Biologics Inc.19,283,7447.2%EDGAR
SC 13G2020-12-21VIKING GLOBAL INVESTORS LP4D Molecular Therapeutics Inc.3,937,91414.9%EDGAR
SC 13G2020-12-21VIKING GLOBAL INVESTORS LPAbCellera Biologics Inc.19,283,7447.2%EDGAR
SC 13G2020-10-05VIKING GLOBAL INVESTORS LPPMV Pharmaceuticals, Inc.2,641,8406.1%EDGAR
SC 13G2020-09-28VIKING GLOBAL INVESTORS LPAthira Pharma, Inc.2,120,6536.9%EDGAR
SC 13G2020-08-31VIKING GLOBAL INVESTORS LPInhibrx, Inc.5,125,64713.6%EDGAR
SC 13G2020-08-10VIKING GLOBAL INVESTORS LPVertex, Inc.1,852,2698.2%EDGAR
SC 13G2020-08-10VIKING GLOBAL INVESTORS LPNuance Communications, Inc.14,347,0165.1%EDGAR
SC 13G2020-07-27VIKING GLOBAL INVESTORS LPGoHealth, Inc.4,559,0925.4%EDGAR
SC 13G2020-04-15VIKING GLOBAL INVESTORS LPZentalis Pharmaceuticals, Inc.4,443,28413.0%EDGAR
SC 13G2020-03-10VIKING GLOBAL INVESTORS LPChange Healthcare Inc.7,852,9736.3%EDGAR
SC 13G/A2020-02-11VIKING GLOBAL INVESTORS LPBERRY GLOBAL GROUP, INC.00.0%EDGAR
SC 13G/A2020-02-11VIKING GLOBAL INVESTORS LPEidos Therapeutics, Inc.00.0%EDGAR
SC 13G/A2020-02-11VIKING GLOBAL INVESTORS LPChewy, Inc.2,896,4235.4%EDGAR
SC 13G/A2020-02-11VIKING GLOBAL INVESTORS LPMIDDLEBY CORP1,856,7303.3%EDGAR
SC 13G/A2020-02-11VIKING GLOBAL INVESTORS LPModerna, Inc.3,321,7551.0%EDGAR
SC 13G/A2020-02-11VIKING GLOBAL INVESTORS LPaTYR PHARMA INC816,7289.4%EDGAR
SC 13G2020-02-11VIKING GLOBAL INVESTORS LPAdaptive Biotechnologies Corp38,406,60730.9%EDGAR
SC 13G2020-01-21VIKING GLOBAL INVESTORS LPCanada Goose Holdings Inc.3,033,1865.2%EDGAR
SC 13G2019-12-12VIKING GLOBAL INVESTORS LPChewy, Inc.3,650,5286.8%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.